2022
DOI: 10.1016/j.thromres.2022.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 17 publications
(23 reference statements)
0
1
0
Order By: Relevance
“…Data about whether the type of drug therapy (DOACs or Vit K antagonists) may influence QoL are conflicting. Some studies report that QoL is better in patients receiving DOACs over Vit K antagonists [ 38 ], while others challenge this finding [ 39 ]. The discrepancies among studies may be attributed to the differences in sample size among studies.…”
Section: Mental Health Aspects Of Pulmonary Embolismmentioning
confidence: 99%
“…Data about whether the type of drug therapy (DOACs or Vit K antagonists) may influence QoL are conflicting. Some studies report that QoL is better in patients receiving DOACs over Vit K antagonists [ 38 ], while others challenge this finding [ 39 ]. The discrepancies among studies may be attributed to the differences in sample size among studies.…”
Section: Mental Health Aspects Of Pulmonary Embolismmentioning
confidence: 99%